Skip to content

Methanamine;(2S)-N-methyl-2-[[(E)-3-(5-methylthiophen-2-yl)prop-2-enoyl]amino]butanediamide

C15H27N5O3S — CID 159425816

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACmethanamine;(2S)-N-methyl-2-[[(E)-3-(5-methylthiophen-2-yl)prop-2-enoyl]amino]butanediamide
SMILESCN.CN.CNC(=O)[C@H](CC(N)=O)NC(=O)/C=C/c1ccc(C)s1
InChIInChI=1S/C13H17N3O3S.2CH5N/c1-8-3-4-9(20-8)5-6-12(18)16-10(7-11(14)17)13(19)15-2;2*1-2/h3-6,10H,7H2,1-2H3,(H2,14,17)(H,15,19)(H,16,18);2*2H2,1H3/b6-5+;;/t10-;;/m0../s1
InChIKeyLQIJLBVTTBDBNU-VVYNGRBTSA-N
MW357.48 g/mol
LogP-0.67
Rot. Bonds6

About Methanamine;(2S)-N-methyl-2-[[(E)-3-(5-methylthiophen-2-yl)prop-2-enoyl]amino]butanediamide

Methanamine;(2S)-N-methyl-2-[[(E)-3-(5-methylthiophen-2-yl)prop-2-enoyl]amino]butanediamide (PubChem CID 159425816) has the molecular formula C15H27N5O3S and a molecular weight of 357.48 g/mol. Its IUPAC name is methanamine;(2S)-N-methyl-2-[[(E)-3-(5-methylthiophen-2-yl)prop-2-enoyl]amino]butanediamide.

Molecular Properties

Compound NameMethanamine;(2S)-N-methyl-2-[[(E)-3-(5-methylthiophen-2-yl)prop-2-enoyl]amino]butanediamide
PubChem CID159425816
Molecular FormulaC15H27N5O3S
Molecular Weight357.48 g/mol
Exact Mass357.18
IUPAC Namemethanamine;(2S)-N-methyl-2-[[(E)-3-(5-methylthiophen-2-yl)prop-2-enoyl]amino]butanediamide
SMILESCN.CN.CNC(=O)[C@H](CC(N)=O)NC(=O)/C=C/c1ccc(C)s1
InChIInChI=1S/C13H17N3O3S.2CH5N/c1-8-3-4-9(20-8)5-6-12(18)16-10(7-11(14)17)13(19)15-2;2*1-2/h3-6,10H,7H2,1-2H3,(H2,14,17)(H,15,19)(H,16,18);2*2H2,1H3/b6-5+;;/t10-;;/m0../s1
InChIKeyLQIJLBVTTBDBNU-VVYNGRBTSA-N
XLogP-0.67
TPSA153.33 Ų
H-Bond Donors5
H-Bond Acceptors6
Rotatable Bonds6
Heavy Atoms24
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500357.48
LogP ≤ 5-0.67
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze Methanamine;(2S)-N-methyl-2-[[(E)-3-(5-methylthiophen-2-yl)prop-2-enoyl]amino]butanediamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Methanamine;(2S)-N-methyl-2-[[(E)-3-(5-methylthiophen-2-yl)prop-2-enoyl]amino]butanediamide?
The IUPAC name of Methanamine;(2S)-N-methyl-2-[[(E)-3-(5-methylthiophen-2-yl)prop-2-enoyl]amino]butanediamide (CID 159425816) is methanamine;(2S)-N-methyl-2-[[(E)-3-(5-methylthiophen-2-yl)prop-2-enoyl]amino]butanediamide.
What is the SMILES notation for Methanamine;(2S)-N-methyl-2-[[(E)-3-(5-methylthiophen-2-yl)prop-2-enoyl]amino]butanediamide?
The canonical SMILES for Methanamine;(2S)-N-methyl-2-[[(E)-3-(5-methylthiophen-2-yl)prop-2-enoyl]amino]butanediamide is CN.CN.CNC(=O)[C@H](CC(N)=O)NC(=O)/C=C/c1ccc(C)s1.
What is the InChIKey of Methanamine;(2S)-N-methyl-2-[[(E)-3-(5-methylthiophen-2-yl)prop-2-enoyl]amino]butanediamide?
The InChIKey is LQIJLBVTTBDBNU-VVYNGRBTSA-N. The full InChI is InChI=1S/C13H17N3O3S.2CH5N/c1-8-3-4-9(20-8)5-6-12(18)16-10(7-11(14)17)13(19)15-2;2*1-2/h3-6,10H,7H2,1-2H3,(H2,14,17)(H,15,19)(H,16,18);2*2H2,1H3/b6-5+;;/t10-;;/m0../s1.
What are the key properties of Methanamine;(2S)-N-methyl-2-[[(E)-3-(5-methylthiophen-2-yl)prop-2-enoyl]amino]butanediamide?
Methanamine;(2S)-N-methyl-2-[[(E)-3-(5-methylthiophen-2-yl)prop-2-enoyl]amino]butanediamide has a molecular weight of 357.48 g/mol, XLogP of -0.67, 6 rotatable bonds, 5 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for Methanamine;(2S)-N-methyl-2-[[(E)-3-(5-methylthiophen-2-yl)prop-2-enoyl]amino]butanediamide is sourced from PubChem (CID 159425816), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.